Primäres ZNS-Lymphom: Gute Langzeit-DatenIn recent years, there have been major advances in the treatment of multiple myeloma. Among previously untreated patients, different combinations of dexamethasone, lenalidomide, thalidomide, and bortezomib have produced overall response rates of 80%-90% with ...
ZNS LymphomTarget-TherapieImmuncheckpointinhibitorSome important knowledge has recently been gained on primary central nervous system lymphomas (PCNSL) despite its rarity. This article summarizes the most relevant progress in the diagnostics and therapy of PCNSL and discusses future directions. Reference ...